Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0000805928-21-000057

Options or other derivatives

  • Chief R&D Officer acquired 50,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Scopelianos Angelo · Chief R&D Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-03-16 Grant or award : show line 1 in the form Employee Stock Option (right to purchase) +34,000 34,000 D
2021-03-16 Grant or award : show line 2 in the form Restricted Stock Units +16,500 16,500 D
Loading xslF345X03/wf-form4_161610437741856.xml…